The Unregulated World of Peptides: A Legal Minefield for Providers Holt Law FDA moves toward easing restrictions on certain peptides BioPharma Dive The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and BPC 157: Experimental Peptide Creates Risk for Athletes Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future Perspectives